CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities
Net loss	$ (1,034,569)	$ (17,701,158)
Adjustments to reconcile net loss to cash used in operating activities
Depreciation and amortization	6,524	5,806
Bad debt	(28,936)	9,328
Stock-based compensation		13,504,200
Gain on disposition	(50,750)
Amortization of debt discount	76,451	62,768
Loss on settlement of debt	393,500	2,871,450
Change in operating assets and liabilities
Accounts and taxes receivable	(46,125)	(35,362)
Prepaid expense		561,764
Inventory	14,671	82,254
Deferred revenue	(6,748)
Accounts payable and accrued liabilities	367,021	136,291
Operating lease right-of-use liability	(4,100)	(4,179)
Net cash used in operating activities	(313,061)	(506,838)
Cash flows from investing activities
Net cash used in investing activities
Cash flow from financing activities
Advances from related party	52,266	97,079
Repayment of advances to related party	(20,749)	(71,239)
Proceeds from notes payable	105,114
Repayment of notes payable	(7,044)
Proceeds from promissory notes	174,685
Net cash provided by financing activities	304,272	25,840
Change in foreign exchange	267	(3,166)
Net change in cash	(8,522)	(484,164)
Cash, beginning of the period	17,137	533,295
Cash, end of the period	8,615	49,131
Cash paid during the year
Interest paid
Income taxes paid
Supplemental disclosure of non-cash investing and financing activities
Stock issued to settle due to related party	188,871
Stock issued to settle promissory note - related party	85,922
Stock issued to settle non-redeemable convertible notes	439,420	2,974,290
Stock issued for prepaid expense		2,288,000
Transfer of accounts payable and accrued liabilities to promissory notes		85,285
Deemed dividend - Series A Stock modification		1,396,721
Deemed contribution - Series B Stock modification		1,354,515
Deemed contribution - Series C Stock modification		834,001
Deemed contribution - Series D Stock modification		$ 749,085